Related Experiment Video
Updated: Jun 27, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
A Dunnett-Bonferroni-based parallel gatekeeping procedure for dose-response clinical trials with multiple endpoints
Haiyan Xu1, Isaac Nuamah, Jingyi Liu
1Clinical Biostatistics, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ 08560, USA. hxu22@its.jnj.com
This study introduces a new Dunnett-Bonferroni method for clinical trials with multiple endpoints. This approach offers a practical and minimally less powerful alternative to existing methods, avoiding complex assumptions.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Statistical Methods
Background:
- Existing Dunnett-based parallel gatekeeping procedures in dose-response trials with multiple endpoints rely on assumptions difficult to justify.
- These assumptions include approximating joint distributions with multivariate-t and accurately estimating correlations, which can be challenged by regulatory agencies.
Purpose of the Study:
- To propose a novel Dunnett-Bonferroni-based parallel gatekeeping procedure for dose-response clinical trials with multiple endpoints.
- To relax restrictive assumptions of existing methods while maintaining high statistical power and ease of implementation.
Main Methods:
- The proposed method adapts the Dunnett-based parallel gatekeeping strategy by incorporating the Bonferroni inequality.
- Type I error rate is split among families, avoiding the need for multivariate-t distribution approximations or precise correlation estimations.
Main Results:
- The Dunnett-Bonferroni-based procedure avoids assumptions that may face regulatory scrutiny.
- While potentially slightly less powerful than the Dunnett-based method, the power loss is minimal.
- The proposed method is generally easier to implement than the traditional Dunnett-based procedure.
Conclusions:
- The Dunnett-Bonferroni-based parallel gatekeeping procedure offers a robust and practical alternative for clinical trials with multiple endpoints.
- It provides a statistically sound approach that is more amenable to regulatory review and simpler for researchers to apply.
Related Concept Videos
Dose Response Curve: Conventional Versus Nonmonotonic
Dose-Response Relationship: Selectivity and Specificity
Dose-Response Relationship: Potency and Efficacy
Dose-Response Relationship: Overview
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Bioavailability Study Design: Single Versus Multiple Dose Studies

